Sort
25,944 grants matching “neurodegeneration”
Advanced Mass Spectrometry Facility
$783,233David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Mechanisms of Prion Protein Toxicity
$782,968David A Harris · Boston University Medical Campus · R01 · FY2023 · NS
Amyloid Pathology and Cognition in Normal Elderly
$782,946William E Klunk · University Of Pittsburgh At Pittsburgh · RF1 · FY2016 · AG
Cellular and Genetic Origins of Astrocytes
$782,850David H Rowitch · University Of California, San Francisco · R01 · FY2009 · NS
Genetic Drivers of Resilience to Alzheimer's Disease
$782,680Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2020 · AG
Descending Modulation of Nerve Injury and Injury-Evoked Pain
$782,665Toni Shippenberg · National Institute On Drug Abuse · ZIA · FY2011 · DA
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimer's
$782,656Aimee Kao · University Of California, San Francisco · R01 · FY2022 · AG
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimer's
$782,656Aimee Kao · University Of California, San Francisco · R01 · FY2021 · AG
Physical exercise and Blood-brain communication: exosomes, Klotho and choroid plexus
$782,487Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
$782,471Luciano D'adamio · Rbhs-New Jersey Medical School · R01 · FY2022 · AG
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
$782,471Luciano D'adamio · Rbhs-New Jersey Medical School · R01 · FY2021 · AG
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
$782,471Luciano D'adamio · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AG
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
$782,471Luciano D'adamio · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AG
Apolipoprotein E and Alzheimer's Disease: Mitochondrial Dysfunction and Neurodegeneration
$782,374Robert W. Mahley · J. David Gladstone Institutes · R56 · FY2018 · AG
Role of central and peripheral immune crosstalk in FTD-Grn neurodegeneration
$782,364Marialourdes G Tansey · Indiana University Indianapolis · R01 · FY2025 · NS
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$782,326David Dale Thomas · University Of Minnesota · R01 · FY2020 · HL
Immune Cells in Alzheimerâs Disease and Related Dementias in the Jackson Heart Study
$782,288Laura M Raffield · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AG
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimer's
$782,253Aimee Kao · University Of California, San Francisco · R01 · FY2020 · AG
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research
$782,114Lee E Goldstein · Boston University Medical Campus · R01 · FY2025 · AG
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: Cognition (ROMA:Cog)
$781,935Ruth Marie Masterson Creber · Columbia University Health Sciences · R01 · FY2024 · NS
A futility trial of sirolimus in multiple system atrophy
$781,753Horacio Kaufmann · New York University School Of Medicine · R01 · FY2020 · NS
Design And Development Of Experimental Therapeutics
$781,688Nigel H. Greig · Aging · Z01 · FY2007 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD
$781,622Kyrana Tsapkini · Johns Hopkins University · R01 · FY2024 · AG
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease
$781,587Yury Miller · University Of California, San Diego · R01 · FY2024 · AG
Transcranial direct current stimulation in typical and atypical Alzheimer's disease
$781,365Kyrana Tsapkini · Johns Hopkins University · R01 · FY2020 · AG